HEALTH-RELATED QUALITY OF LIFE IN HER2-POSITIVE EARLY BREAST CANCER WOMAN USING TRASTUZUMAB: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Khoirunnisa, S. [1 ]
Suryanegara, F. D. A. [1 ]
Setiawan, D. [2 ]
Postma, M. J. [1 ]
机构：
[1] Univ Med Ctr Groningen, Groningen, GR, Netherlands
[2] Univ Muhammadiyah Purwokerto, Banyumas, JT, Indonesia
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P64
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [1] Health-related quality of life in Her2-positive early breast cancer woman using trastuzumab: A systematic review and meta-analysis
    Khoirunnisa, Sudewi Mukaromah
    Suryanegara, Fithria Dyah Ayu
    Setiawan, Didik
    Postma, Maarten Jacobus
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [2] A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab
    Khoirunnisa, Sudewi Mukaromah
    Suryanegara, Fithria Dyah Ayu
    de Jong, Lisa Aniek
    Setiawan, Didik
    Postma, Maarten Jacobus
    [J]. PHARMACOECONOMICS-OPEN, 2024, 8 (04) : 511 - 524
  • [3] Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis
    Wilson, Florence R.
    Coombes, Megan E.
    Brezden-Masley, Christine
    Yurchenko, Mariya
    Wylie, Quinlan
    Douma, Reuben
    Varu, Abhishek
    Hutton, Brian
    Skidmore, Becky
    Cameron, Chris
    [J]. SYSTEMATIC REVIEWS, 2018, 7
  • [4] Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis
    Florence R. Wilson
    Megan E. Coombes
    Christine Brezden-Masley
    Mariya Yurchenko
    Quinlan Wylie
    Reuben Douma
    Abhishek Varu
    Brian Hutton
    Becky Skidmore
    Chris Cameron
    [J]. Systematic Reviews, 7
  • [5] Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
    Wilson, Florence R.
    Coombes, Megan E.
    Wylie, Quinlan
    Yurchenko, Mariya
    Brezden-Masley, Christine
    Hutton, Brian
    Skidmore, Becky
    Cameron, Chris
    [J]. SYSTEMATIC REVIEWS, 2017, 6
  • [6] Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
    Genuino, Anne Julienne
    Chaikledkaew, Usa
    The, Due Ong
    Reungwetwattana, Thanyanan
    Thakkinstian, Ammarin
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 815 - 824
  • [7] Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
    Florence R. Wilson
    Megan E. Coombes
    Quinlan Wylie
    Mariya Yurchenko
    Christine Brezden-Masley
    Brian Hutton
    Becky Skidmore
    Chris Cameron
    [J]. Systematic Reviews, 6
  • [8] Trastuzumab deruxtecan for HER2-positive breast cancer brain metastasis: A systematic review and meta-analysis
    Michelon, I. F.
    Vilbert, M. Silveira
    Marinho, A. D.
    Castro, C. E. D. R.
    Dacoregio, M. I.
    Stecca, C.
    Soares, L. R.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S357 - S357
  • [9] Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: A systematic review and meta-analysis
    Valachis, Antonis
    Mauri, Davide
    Polyzos, Nikolaos P.
    Chlouverakis, Grigoris
    Mavroudis, Dimitrios
    Georgoulias, Vassilios
    [J]. BREAST, 2011, 20 (06): : 485 - 490
  • [10] Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies
    Martin, Antony P.
    Downing, Jennifer
    Cochrane, Madeleine
    Collins, Brendan
    Francis, Ben
    Haycox, Alan
    Alfirevic, Ana
    Pirmohamed, Munir
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 130 : 92 - 107
12345